IP Library Granted Patent US 10,006,002
Granted Patent B2
US 10,006,002 · App. 14/960,509 · Granted Jun 26, 2018

Method of assembling a 3D tissue culturing scaffold

Inventor: Francesco Curcio (Udine, IT)
Assignee: VIVABIOCELL S.P.A.
C12N5/0062A61K9/00A61K35/32A61L27/18A61L27/50A61L27/56C12M21/08C12M23/02C12M25/14A61L2300/64B33Y10/00B33Y50/02C12N2533/30C12N2535/00C12N2537/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,006,002
App. No.
14/960,509
Granted
Jun 26, 2018
Kind
B2
Abstract

A continuous device for culturing mammalian cells in a three-dimensional structure for the transplantation or implantation in vivo is described. The culturing device comprises (a) a scaffold formed by a matrix of interconnected growth surfaces spaced at regular intervals and (b) a fluid distribution means at the inlet and the exit of the growth areas. The device is particularly useful for culturing bone cells for dental implants or bone reconstruction.

Claims (19)

1. A method of assembling a 3D tissue culturing scaffold comprising:

defining a 3D matrix of interconnected growth surfaces of a 3D tissue culture scaffold having regular and repetitive 3D structures defining open spaces along x, y, and z Cartesian axes;

determining the dimensions of the open spaces for an optimized fluid flow distribution throughout the defined scaffold; and

producing the 3D tissue culture scaffold with open spaces for the optimized fluid flow distribution by assembling 2D layers over each other.

2. The method of claim 1 , wherein the determined dimensions of the open spaces for the optimized fluid flow analysis distribution are confirmed by computational analysis software.

3. The method of claim 1 , further comprising adjusting channels of the open spaces to facilitate uniform flow distribution to the growth surfaces.

4. The method of claim 1 , wherein the 3D structures forming the matrix have at least one of the following shapes: cylindrical shape, rectangular shape, and hexagonal shape.

5. The method of claim 1 , wherein the interconnected growth surfaces comprise solid cylindrical structures.

6. The method of claim 1 , wherein the interconnected growth surfaces are textured.

7. The method of claim 1 , wherein the dimensions of the open spaces fall within the range from 0.7 mm to 3 mm.

8. The method of claim 7 , wherein the dimensions of the open spaces fall within the range 1 mm to 2 mm.

9. The method of claim 1 , wherein the step of producing the 3D tissue culture scaffold includes assembling 2D layers of a biocompatible material.

10. The method of claim 9 , wherein the biocompatible material includes at least one of the following: polycaprolacton, polyethylene oxide terephthalate, polyamide, poly-L-lactic acid, polyglycolic acid, collagen, fibronectin, and hydroxyapatite.

11. The method of claim 1 , wherein the 3D tissue culture scaffold comprises a cubic shape.

12. The method of claim 1 , wherein the 3D tissue culture scaffold comprises an anatomically correct shape.

13. The method of claim 1 , wherein the 3D tissue culture scaffold comprises an overall cylindrical shape.

14. The method of claim 1 , wherein the interconnected growth surfaces comprise fibers.

15. The method of claim 1 , wherein the 3D tissue culture scaffold further comprises a central support.

16. The method of claim 15 , further comprising configuring the central support to couple to inlet and outlet fluid distribution devices.

Priority Claims (1)
EP 09179465 · Dec 16, 2009 · regional
Continuity (3)
Continuation 14039011 · Sep 27, 2013
Continuation 13515685
Related Publication 20160108358A1 · Apr 21, 2016